rs476569

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001737.5(C9):​c.78-10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.522 in 1,412,842 control chromosomes in the GnomAD database, including 195,334 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 28533 hom., cov: 32)
Exomes 𝑓: 0.51 ( 166801 hom. )

Consequence

C9
NM_001737.5 intron

Scores

2
Splicing: ADA: 0.0001237
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.911

Publications

12 publications found
Variant links:
Genes affected
C9 (HGNC:1358): (complement C9) This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]
C9 Gene-Disease associations (from GenCC):
  • complement component 9 deficiency
    Inheritance: Unknown, AR Classification: STRONG, MODERATE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BP6
Variant 5-39342206-C-T is Benign according to our data. Variant chr5-39342206-C-T is described in ClinVar as Benign. ClinVar VariationId is 402465.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.811 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C9NM_001737.5 linkc.78-10G>A intron_variant Intron 1 of 10 ENST00000263408.5 NP_001728.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C9ENST00000263408.5 linkc.78-10G>A intron_variant Intron 1 of 10 1 NM_001737.5 ENSP00000263408.4

Frequencies

GnomAD3 genomes
AF:
0.595
AC:
90348
AN:
151956
Hom.:
28480
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.818
Gnomad AMI
AF:
0.434
Gnomad AMR
AF:
0.635
Gnomad ASJ
AF:
0.598
Gnomad EAS
AF:
0.507
Gnomad SAS
AF:
0.516
Gnomad FIN
AF:
0.406
Gnomad MID
AF:
0.640
Gnomad NFE
AF:
0.492
Gnomad OTH
AF:
0.618
GnomAD2 exomes
AF:
0.533
AC:
133758
AN:
250884
AF XY:
0.526
show subpopulations
Gnomad AFR exome
AF:
0.829
Gnomad AMR exome
AF:
0.620
Gnomad ASJ exome
AF:
0.597
Gnomad EAS exome
AF:
0.505
Gnomad FIN exome
AF:
0.399
Gnomad NFE exome
AF:
0.493
Gnomad OTH exome
AF:
0.542
GnomAD4 exome
AF:
0.513
AC:
647207
AN:
1260768
Hom.:
166801
Cov.:
19
AF XY:
0.512
AC XY:
326488
AN XY:
637618
show subpopulations
African (AFR)
AF:
0.836
AC:
25062
AN:
29980
American (AMR)
AF:
0.625
AC:
27803
AN:
44478
Ashkenazi Jewish (ASJ)
AF:
0.596
AC:
14884
AN:
24970
East Asian (EAS)
AF:
0.531
AC:
20609
AN:
38826
South Asian (SAS)
AF:
0.513
AC:
42176
AN:
82272
European-Finnish (FIN)
AF:
0.398
AC:
21235
AN:
53308
Middle Eastern (MID)
AF:
0.604
AC:
3244
AN:
5370
European-Non Finnish (NFE)
AF:
0.500
AC:
463505
AN:
927756
Other (OTH)
AF:
0.533
AC:
28689
AN:
53808
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
15230
30461
45691
60922
76152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12898
25796
38694
51592
64490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.595
AC:
90462
AN:
152074
Hom.:
28533
Cov.:
32
AF XY:
0.591
AC XY:
43923
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.818
AC:
33966
AN:
41502
American (AMR)
AF:
0.635
AC:
9694
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.598
AC:
2075
AN:
3470
East Asian (EAS)
AF:
0.507
AC:
2611
AN:
5150
South Asian (SAS)
AF:
0.517
AC:
2488
AN:
4816
European-Finnish (FIN)
AF:
0.406
AC:
4296
AN:
10576
Middle Eastern (MID)
AF:
0.644
AC:
188
AN:
292
European-Non Finnish (NFE)
AF:
0.492
AC:
33433
AN:
67964
Other (OTH)
AF:
0.622
AC:
1315
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1758
3516
5273
7031
8789
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.547
Hom.:
39848
Bravo
AF:
0.623
Asia WGS
AF:
0.580
AC:
2022
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 05, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.0070
DANN
Benign
0.21
PhyloP100
-0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00012
dbscSNV1_RF
Benign
0.056
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs476569; hg19: chr5-39342308; COSMIC: COSV54677015; API